This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend the Oncology Professional Care Show

If you would like more information on oncology, please refer to the NHS website.

Visit the NHS website?

Sidebar CTAs

Advanced Accelerator Applications (UK & Ireland) Ltd

Advanced Accelerator Applications (UK & Ireland) Ltd

Stand: B52

Advanced Accelerator Applications (AAA), a Novartis company, is an innovative medicines company focused on the development of products for targeted radioligand therapy and precision radioligand imaging.

Founded in 2002, by physicist Stefano Buono, who was inspired to pursue medical applications for certain research conducted during his tenure at the European Organization for Nuclear Research, or CERN, with Nobel laureate Carlo Rubbia.

AAA is committed to advancing the science in radioligand therapy, with the aim of identifying enhanced detection and diagnostic approaches and developing innovative treatments that improve patient outcomes.


Edison House, 223-231 Old Marylebone Road
United Kingdom
Visit website

Contact Exhibitor

View all Exhibitors